clindamycine fresenius kabi 150 mg/ml sol. inj. i.m./i.v. amp.
fresenius kabi sa-nv - phosphate de clindamycine 178,23 mg/ml - eq. clindamycine 150 mg/ml - solution injectable - 150 mg/ml - phosphate de clindamycine 178.23 mg/ml - clindamycin
clindamycine fresenius kabi 150 mg/ml sol. inj. i.m./i.v. amp.
fresenius kabi sa-nv - phosphate de clindamycine 178,23 mg/ml - eq. clindamycine 150 mg/ml - solution injectable - 150 mg/ml - phosphate de clindamycine 178.23 mg/ml - clindamycin
clindamycine fresenius kabi 150 mg/ml sol. inj. i.m./i.v. amp.
fresenius kabi sa-nv - phosphate de clindamycine 178,23 mg/ml - eq. clindamycine 150 mg/ml - solution injectable - 150 mg/ml - phosphate de clindamycine 178.23 mg/ml - clindamycin
clindamycin sandoz 300 mg gél.
sandoz sa-nv - chlorhydrate de clindamycine 348,4 mg - eq. clindamycine 300 mg - gélule - 300 mg - chlorhydrate de clindamycine 348.4 mg - clindamycin
clindamycin sandoz 150 mg gél.
sandoz sa-nv - chlorhydrate de clindamycine 169,235 mg - eq. clindamycine 150 mg - gélule - 150 mg - chlorhydrate de clindamycine 169.235 mg - clindamycin
clindamycin phosphat pfizer i.v./i.m. 300 mg solution injectable
pfizer ag - clindamycinum - solution injectable - clindamycinum 300 mg ut clindamycini phosphas, dinatrii edetas, natrii hydroxidum q.s. ad ph, alcohol benzylicus 18 mg, aqua ad iniectabile ad solutionem pro 2 ml corresp. natrium 17.92 mg. - les maladies infectieuses - synthetika
clindamycin phosphat pfizer i.v./i.m. 600 mg solution injectable
pfizer ag - clindamycinum - solution injectable - clindamycinum 600 mg ut clindamycini phosphas, dinatrii edetas, natrii hydroxidum q.s. ad ph, alcohol benzylicus 36 mg, aqua ad iniectabile ad solutionem pro 4 ml corresp. natrium 35.84 mg. - les maladies infectieuses - synthetika
clindamycin [phosphat]-mepha i.v./i.m. 600 mg/4 ml konzentrat zur herstellung einer infusionslösung i.v. / injektionslösung i.m.
mepha pharma ag - clindamycinum - konzentrat zur herstellung einer infusionslösung i.v. / injektionslösung i.m. - clindamycinum 600 mg ut clindamycini phosphas, dinatrii edetas, natrii hydroxidum, alcohol benzylicus 37.8 mg, aqua ad iniectabile ad solutionem pro 4 ml corresp. natrium max. 34.04 mg. - les maladies infectieuses - synthetika
clindamycin [phosphat] sandoz i.v./i.m. 600 mg/4ml konzentrat zur herstellung einer infusionslösung i.v. / injektionslösung i.m
sandoz pharmaceuticals ag - clindamycinum - konzentrat zur herstellung einer infusionslösung i.v. / injektionslösung i.m - clindamycinum 600 mg ut clindamycini phosphas, dinatrii edetas, natrii hydroxidum, alcohol benzylicus 37.8 mg, aqua ad iniectabile ad solutionem pro 4 ml corresp. natrium max. 34.04 mg. - les maladies infectieuses - synthetika
clindamycin injection in 5% dextrose solution
baxter corporation - clindamycine (phosphate de clindamycine) - solution - 300mg - clindamycine (phosphate de clindamycine) 300mg - lincomycins